Pivot Pharmaceuticals (CSE:PVOT) announced a letter of intent with Pharmaflorx, a late stage ACMPR applicant in Quebec, for the supply a minimum 1,000 kilograms of cannabis oils and isolates per year.

As quoted in the press release:


Pivot will purchase a minimum of 1,000 [kilograms]/year of cannabis oils or isolates from PFX for manufacturing of Pivot’s patented portfolio of biocannabis products. Upon receipt of appropriate licenses in Canada, Pivot intends to supply both the Canadian and European Union markets with its suite of patented, formulated and bioavailable products, including [cannabidiol] CBD and/or [tetrahydrocannabinol] THC-based creams, lotions, capsules, tablets, bulk powder, infused beverages and pet supplements, where regulations permit.

Pharmaflorx’ Gatineau facility will be a multi-level state-of-the-art operation. With 22 independent grow rooms, vertical growing and a full LED lighting system, PFX endeavours to become the most productive facility in the cannabis industry with respect to grams per square foot. Using the latest in active soil technology and nutrient packed medium, PFX aims to reduce labour costs and have a fast turnover rate of quality product. Their two-story facility gives PFX the opportunity to produce 4 levels of vertically-grown product and to maximize the use of their 8-acre property for future expansion. A planned Phase II expansion will see PFX add 240,000 [square feet] of production space to reach a production capacity of over 125,000 [kilograms]/year.

Louis-Alexandre Morin, co-founder and CEO of Pharmaflorx comments, “We are delighted to be selected as a supplier to Pivot Pharmaceuticals, a leader in the cannabis derivatives sector. Pharmaflorx is committed to providing high-quality medical grade cannabis oils and isolates to both consumers and strategic partners, which this agreement demonstrates. We believe this agreement represents the beginning of a strong partnership with Pivot, one which will benefit both companies and consumers for many years.”

Click here to read the full press release.

CANBUD Distribution Corp. (CSE:CBDX, FSE:CD0) leverages on timely and methodical execution of its revenue generating plan. It operates a trinitarian enterprise model in the plant-based protein, psychedelic pharmaceutical and non-psychedelic nutraceutical, and hemp cannabinoids (CBD) spaces. (www.canbudcorp.com).

Keep reading... Show less

(TheNewswire)

Keep reading... Show less

Market entry will address pent-up demand in the Japanese & Philippine markets for TRACE proprietary plant-based mineral formulation and wellness-focused products

Emerging leader in innovative health and wellness beverages and natural products, BevCanna Enterprises Inc. ( CSE:BEV , Q:BVNNF , FSE:7BC ) (“ BevCanna ” or the “ Company ”) announces today that has entered into an exclusive sales agency distribution agreement with Yokohama-based Mirai Marketing Inc. (“Mirai”) to bring Naturo Group’s TRACE proprietary plant-based mineral consumer products to Mirai’s extensive Japanese and Philippine sales and distribution networks.

Keep reading... Show less

Further to its press release dated April 12, 2021, Ayurcann Holdings Corp. ( CSE: AYUR ) (the “ Company ” or “ Ayurcann ”), is pleased to announce that it has oversubscribed and upsized its non-brokered private placement (the “Offering”) due to strong investor demand. The Company now anticipates that the Offering will be completed for gross proceeds of not less than $550,000.00, consisting of not less than 2,910,053 units (“Units”) at a price of $0.189 per Unit. Each Unit is comprised of one common share of the Company (a “Common Share”) and one half of one Common Share purchase warrant (a “Warrant”). Each Warrant is exercisable to acquire one Common Share at an exercise price of C$0.38 per Common Share for a period of 36 months from the date of closing of the Offering (the “Closing Date”), scheduled for April 22, 2021. The Units will have a hold period of four months and one day from the date of issuance.

Ayurcann CEO Igal Sudman commented: “We are very pleased with the demand we are seeing for the Offering. The feedback we have received to date is showing that our business is resonating with investors. We’re looking forward to closing the offering and proceeding with the planned Phase 2 build out, which will help greatly increase our facility’s capacity.”

Keep reading... Show less

UK InstaCoin APP Promises to Open NFTs up to the Masses through Social Media

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) is pleased to provide an update on its recent investment in InstaCoin Technologies Ltd., a newly formed UK entity

Keep reading... Show less